We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Bayer Aktiengesellschaft (PK) | USOTC:BAYRY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 7.60 | 7.62 | 7.64 | 179 | 14:06:02 |
From May 2019 to May 2024
By Kim Richters
Germany's Bayer AG (BAYN.XE) confirmed on Monday that a U.S. trial relating to Monsanto's glyphosate-based herbicide Roundup has been postponed to next year.
The trial, originally scheduled for Oct. 15 in St. Louis, Missouri, where Monsanto is headquartered, has now been moved to next year, Bayer said. There are no further trials scheduled for 2019, it said.
German newspaper Handelsblatt first reported the rescheduling on Sunday.
Bayer has faced significant legal challenges since taking over Monsanto last year, with lawsuits from around 18,400 plaintiffs in the U.S. as of July 11. Among the lawsuits are claims that Monsanto's glyphosate-based Roundup could cause cancer.
Bayer will update the plaintiff figure on Oct. 30, when it reports third-quarter results, it said.
Write to Kim Richters at kim.richters@wsj.com
(END) Dow Jones Newswires
October 07, 2019 05:48 ET (09:48 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year Bayer Aktiengesellschaft (PK) Chart |
1 Month Bayer Aktiengesellschaft (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
